Ongoing Review of DMTs Necessary Among Patients With Multiple Sclerosis

January 26th 2021, 8:09pm


Periodic review of treatment safety and monitoring are necessary as medical centers increasingly use newer disease-modifying therapies earlier in the course of multiple sclerosis.

The Role and Rationale for Oral Options in the Treatment of Metastatic Breast Cancer

January 25th 2021, 10:30pm


Breast cancer oncologists explore more recent advances using oral chemotherapies to treat metastatic breast cancer.

Frailty May Increase Hospital Readmission Risk Among Patients With Heart Failure

January 20th 2021, 10:00pm


Both women and men have a greater chance of 90-day hospital readmission when they are considered to be in frail condition from heart failure.

Dr Milena Murray: Social Acceptance Facilitates Access to HIV Care

January 17th 2021, 12:30pm


Consider social determinants of health when trying to help gay and bisexual men, stressed Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy.

Endocrine Society Calls for Negotiated Insulin Prices in Medicare

January 13th 2021, 9:17pm


The statement is aimed at drug companies, policymakers, pharmacy benefit managers, employers, and others, and calls to attention soaring insulin costs, which were the subject of several Congressional hearings in 2019.

Examining the Shift to Value-Based Kidney Care Delivery in 2021

January 12th 2021, 7:20pm


On this episode of Managed Care Cast, we speak with the new chief financial officer of Strive Health, a value-based kidney care company that works with payers and providers to create an integrated care delivery system for chronic kidney disease and end-stage renal disease (ESRD). We discuss the changes coming to nephrology practices, as well as new ways of looking at the whole patient to halt the slide to irreversible ESRD.

Dr Sibel Blau Discusses the Impact of Delayed Cancer Diagnoses on Community Cancer Practices

January 12th 2021, 2:00pm


Telehealth is helpful, but it is not enough to make up for the delay in cancer diagnoses occurring as a result of the pandemic, said Sibel Blau, MD, of Northwest Medical Specialties and Quality Cancer Care Alliance.

Jardiance 1 Step Closer to FDA Approval for Use in Heart Failure

January 11th 2021, 6:04pm


The FDA today accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for Jardiance (empagliflozin), the sodium glucose co-transporter 2 inhibitor being investigated for use in patients with heart failure.

Risk Factors Identified for Chronic Opioid, Benzodiazepine Use After Mastectomy and Breast Reconstruction

January 4th 2021, 9:02pm


An abstract from last month’s San Antonio Breast Cancer Symposium identifies factors linked with longer-term controlled substance use after treatment of breast cancer with mastectomy plus breast reconstruction in women receiving opioids, benzodiazepines, and other sedative/hypnotics.

A Timeline of COVID-19 Developments in 2020

January 1st 2021, 10:00pm


Coronavirus disease 2019 (COVID-19) dominated 2020. This is a look back at how the pandemic evolved and progressed through the year, which closed with the arrival of vaccines, but also continued challenges.